{"id":"doi:10.1016/j.molmet.2020.101090","kind":"review","title":"Glucagon-like peptide-1 receptor co-agonists for treating metabolic disease","authors":["Laurie L. Baggio","Daniel J. Drucker"],"author_count":2,"year":2020,"published":"2020-09-25","venue":"Molecular Metabolism","cited_by":298,"doi":"10.1016/j.molmet.2020.101090","arxiv_id":null,"nct_id":null,"source_url":"https://doi.org/10.1016/j.molmet.2020.101090","archive_url":"https://space-kitty.com/papers/doi:10.1016/j.molmet.2020.101090","updated":null,"pmid":"32987188","pmcid":null,"openalex_id":"W3087889571","pdf_url":"https://www.sciencedirect.com/science/article/pii/S2212877820301642/pdf","abstract":null,"abstract_license":null,"license":"cc-by-nc-nd","is_open_access":true,"retracted":false,"peer_reviewed":null,"categories":["Diabetes Treatment and Management"],"details":null,"provenance":"openalex","attribution":"Metadata and citation counts: OpenAlex (CC0).","topics":[{"slug":"glp1-metabolic","name":"GLP-1 & Incretin Therapies","domain_slug":"medicine"}],"cited_in_dossiers":[{"slug":"glp1-metabolic","title":"GLP-1 & Incretin Therapies: State of the Field (October 2026)","url":"https://space-kitty.com/dossiers/glp1-metabolic"}]}